Organon & Co | OGN - Ingresos Por Ventas





Ventas Cambio Fecha
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Celltrion KRW 1.33T 300B 2026-03
Cspc Pharmaceutical CNY 6.62B 358.95M 2025-09
Deva Holding AS TRY 2.32B 418.58M 2023-09
Dianthus Therapeutics USD 396K 203K 2025-09
Divis Laboratories Ltd INR 26.04B 1.11B 2025-12
Gilead Sciences USD 7.93B 130M 2025-12
Glaxosmithkline GBP 11.52B 3.54B 2025-09
Kangmei Pharma CNY 1.37B 101.16M 2025-09
Knight Therapeutics CAD 92.26M 3.31M 2024-09
Laboratorios Farma EUR 448.66M 67.82M 2023-12
Medical Developments International AUD 21.57M 12.04M 2025-12
Merck USD 16.4B 880M 2025-12
Neuren Pharmaceuticals AUD 42.24M 28.1M 2025-12
Novartis USD 14.36B 478M 2025-09
Organigram Holdings CAD 80.06M 9.27M 2025-09
Organon & Co USD 1.51B 90M 2025-12
Pharma Mar EUR 90.48M 54.78M 2025-12
Qiagen NV USD 457.38M 6.06M 2025-12
Sartorius EUR 927.6M 84.4M 2025-12
Sino Biopharmaceutical CNY 17.57B 4.58B 2025-06
Tilray USD 217.51M 74.75M 2025-12